Antiglycaemic potentials and molecular docking studies of the extracts of Cassia alata L.
Tóm tắt
This study assessed the antiglycaemic properties of the methanolic extracts of the dried leaf of Cassia alata L. through in vitro and in silico approaches. The methanolic crude extract (MCE) of the dried leaf was prepared and partitioned into n-butanol (BPE) and aqueous (ARE) extracts. The antiglycaemic potential was assessed in vitro by studying the inhibitory actions of the extracts with α-amylase, α-glucosidase, and sucrase. The antiglycation capacity of the extracts was evaluated through the inhibition of albumin glycation, thiol oxidation, and β-fibril formation. Previously identified compounds (emodin, quercetin, chrysoeriol, and kaempferol) were docked with α-amylase (1HNY), α-glucosidase (5ZCB), and sucrase-isomaltase (3LPO) using the Pyrex Virtual Screening tool. The results revealed that MCE had the highest inhibitory potential with the lowest IC50 values of 69.67 ± 0.88, 65.54 ± 0.34, and 48.35 ± 1.45 μg/mL for α-amylase, α-glucosidase, and sucrase inhibitions, respectively. The molecular docking studies showed that quercetin and kaempferol had the best docking scores with 1HNY while emodin and chrysoeriol had the best scores towards 5ZCB and 3LPO. MCE and BPE significantly (p < 0.05) inhibited glucose-induced albumin glycation and modification. This study suggested that the extract of the leaf of C. alata could contain a mix of different phytochemicals that could be beneficial in reducing the absorption of glucose and preventing diabetes-induced complications.
Tài liệu tham khảo
Orasanu G, Plutzky J (2009) The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53(5 Suppl):S35–S42
Chawla A, Chawla R, Jaggi S (2016) Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab 20(4):546–551
Meloni G, Meloni T (1996) Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM. Br J Haematol 92(1):159–160
Gale EA (2001) Lessons from triglitazones: a story of drug development. Lancet 357:1870–1875
Monami M, Luzzi C, Lamanna C, Chiasserini V, Addante F, Desideri CM, Masotti G, Marchionni N, Mannucci E (2006) Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin. Diabetes Metab Res Rev 22(6):477–482
Dahlqvist A (1964) Method for assay of intestinal disaccharides. Anal Biochem 7:18–25
Bernfeld P (1955) Amylase, α and β. In: Colowick SP, Kaplan NO (eds) Methods in enzymology. Academic Press, New York, NY, USA, pp 149–158
Kim YM, Jeong YK, Wang MH, Lee YH, Rhee HI (2005) Inhibitory effect of pine extract on alpha-glucosidase activity and postprandial hyperglycaemia. Nutrition 21:756–761
Honda M, Hara Y (1993) Inhibition of rat small intestinal sucrase and α-glucosidase activities by tea polyphenols. Biosci Biotechnol Biochem 57:123–124
Safari M, Sheikh N, Kashani KM (2010) Study on the effect of vitamin C on the in vitro albumin glycation reaction. Iran J Pharm Res 2010:275–279
Furth AJ (1988) Methods for assaying nonenzymatic glycosylation. Anal Biochem 175:347–360
Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77
Klunk WE, Jacob RF, Mason RP (1999) Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol 309:285–305
Liu A, Xu L, Zou Z, Yang S (2009) Studies on chemical constituents from leaves of Cassia alata. Zhongguo Zhong Yao Za Zhi 34(7):861–863
Fernand VE, Dinh DT, Washington SJ, Fakayode SO, Losso JN, van Ravenswaay RO, Warner IM (2008) Determination of pharmacologically active compounds in root extracts of Cassia alata L. by use of high performance liquid chromatography. Talanta. 74(4):896–902 https://doi.org/10.1016/j.talanta.2007.07.033
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717 https://doi.org/10.1038/srep42717
Oso BJ, Olowookere BD (2018) A study on the total phenolics and antioxidant properties of different solvent extracts of dried leaves of Cassia alata (L.) Roxb. Medicinal Plants 10(4):348–352
Oso BJ, Karigidi KO (2019) Inhibitory action of dried leaf of Cassia alata (Linn.) Roxb against lipoxygenase activity and nitric oxide generation. Scientia Agropec 10(2):185–190
Subramanian DP (2001) Venugopal S. Phytochemical investigation of Cassia alata Linn. flowers through various in vitro antioxidant assays. Int J Pharm Tech 3(4):3521–3534
Varghese GK, Bose LV, Habtemariam S (2013) Antidiabetic components of Cassia alata leaves: identification through α-glucosidase inhibition studies. Pharm Biol 51(3):345–349 https://doi.org/10.3109/13880209.2012.729066
Proença C, Freitas M, Ribeiro D, Oliveira EFT, Sousa JLC, Tomé SM, Ramos MJ, Silva AMS, Fernandes PA, Fernandes E (2017) α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure–activity relationship study. J Enzyme Inhib Med Chem 32(1):1216–1228 https://doi.org/10.1080/14756366.2017.1368503
Hara Y, Honda M (1990) The inhibition of alpha amylase by tea polyphenols. Agric Biol Chem 54:1939–1945
Nain P, Saini V, Sharma S, Nain J (2012) Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol 142(1):65–71
Ben Younes A, Ben Salem M, El Abed H, Jarraya R (2018) Phytochemical screening and antidiabetic, antihyperlipidemic, and antioxidant properties of Anthyllis henoniana (Coss.) flowers extracts in an alloxan-induced rats model of diabetes. Evid-Based Complem Alt Med 2018:1–14 https://doi.org/10.1155/2018/8516302
Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ (2010) Virtual screening with AutoDock: theory and practice. Expert Opin Drug Discovery 5(6):597–607
Rauter AP, Martins A, Borges C, Mota-Filipe H, Pinto R, Sepodes B, Justino J (2010) Antihyperglycaemic and protective effects of flavonoids on streptozotocin-induced diabetic rats. Phytother Res 24:S133–S138 https://doi.org/10.1002/ptr.3017
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1–3):3–26 https://doi.org/10.1016/s0169-409x(00)00129-0
Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1(1):55–68 https://doi.org/10.1021/cc9800071
Ma HY, Gao HY, Sun L, Huang J, Xu XM, Wu LJ (2011) Constituents with α-glucosidase and advanced glycation end-product formation inhibitory activities from Salvia miltiorrhiza Bge. J Nat Med 65(1):37–42
Gkogkolou P, Böhm M (2012) Advanced glycation end products-key players in skin aging. Dermatoendocrin 4(3):259–270
Singh VP, Bali A, Singh N, Jaggi AS (2014) Advanced glycation end products and diabetic complications. Kor J Phys Pharm 18(1):1–14
Rout S, Banerjee R (2007) Free radical scavenging, anti-glycation and tyrosinase inhibition properties of a polysaccharide fraction isolated from the rind from Punica granatum. Bioresour Technol 98(16):3159–3163
Emendato A, Milordini G, Zacco E, Sicorello A, Piaz FD, Remo Guerrini R, Thorogate R, Picone D, Pastore A (2018) Glycation affects fibril formation of Aβ peptides. J Biol Chem 293(34):13100–13111 https://doi.org/10.1074/jbc.RA118.002275
Singh B, Nadkarni JR, Vishwakarm RA, Bharate SB, Nivsarkar M, Anandjiwala S (2012) The hydroalcoholic extract of Cassia alata (Linn.) leaves and its major compound rhein exhibits antiallergic activity via mast cell stabilization and lipoxygenase inhibition. J Ethnopharmacol 141(1):469–473
Rekha PD, Vasavi HS, Vipin C, Saptami K, Arun AB (2017) A medicinal herb Cassia alata attenuates quorum sensing in Chromobacterium violaceum and Pseudomonas aeruginosa. Lett Appl Microbiol 64(3):231–238 https://doi.org/10.1111/lam.12710
Yeh WJ, Hsia SM, Lee WH, Wu CH (2017) Polyphenols with antiglycation activity and mechanisms of action: a review of recent findings. J Food Drug Anal 25(1):84–92 https://doi.org/10.1016/j.jfda.2016.10.017